Retractable Technologies EPS RVP
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$0.12
- Latest quarter, Q2 FY26
- $0.09
- Fiscal year 2025
- −$0.42
Retractable Technologies' earnings per share was −$0.12 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.09.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.42 | n/a |
| FY2024 | −$0.42 | n/a |
| FY2023 | −$0.24 | −260% |
| FY2022 | $0.15 | −91% |
| FY2021 | $1.63 | +106% |
| FY2020 | $0.79 | +888% |
| FY2019 | $0.08 | n/a |
| FY2018 | −$0.06 | n/a |
| FY2017 | −$0.14 | n/a |
| FY2016 | −$0.15 | −175% |
| FY2015 | $0.20 | n/a |
| FY2014 | −$0.12 | n/a |
| FY2013 | −$0.26 | n/a |
| FY2012 | −$0.19 | −2000% |
| FY2011 | $0.01 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.09 | n/a | −$0.12 | |
| Q1 FY26 | −$0.14 | n/a | −$0.21 | |
| Q4 FY25 | −$0.08 | −167% | −$0.42 | |
| Q3 FY25 | $0.01 | n/a | −$0.22 | |
| Q2 FY25 | $0.00 | n/a | −$0.30 | |
| Q1 FY25 | −$0.35 | −3600% | −$0.78 | |
| Q4 FY24 | $0.12 | n/a | −$0.42 | |
| Q3 FY24 | −$0.07 | n/a | −$0.54 | |
| Q2 FY24 | −$0.48 | n/a | −$0.61 | |
| Q1 FY24 | $0.01 | −67% | −$0.26 | |
| Q4 FY23 | $0.00 | n/a | −$0.24 | |
| Q3 FY23 | −$0.14 | −188% | −$0.37 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Retractable Technologies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| RVPRetractable Technologies | −$0.12 | |
| NEPHNephros | $0.16 | +33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| Peer median | $0.41 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Retractable Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.